User profiles for Arshiya Mariam
 | Arshiya MariamGraduate Student, Lerner Research Institute, Cleveland Clinic Verified email at ccf.org Cited by 83 |
[HTML][HTML] Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study
Background Improved detection of hepatocellular carcinoma (HCC) is needed, as current
detection methods, such as alpha fetoprotein (AFP) and ultrasound, suffer from poor sensitivity. …
detection methods, such as alpha fetoprotein (AFP) and ultrasound, suffer from poor sensitivity. …
Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis
Reports indicate that coronavirus disease 2019 (COVID-19) may impact pancreatic function
and increase type 2 diabetes (T2D) risk, although real-world COVID-19 impacts on HbA 1c …
and increase type 2 diabetes (T2D) risk, although real-world COVID-19 impacts on HbA 1c …
[HTML][HTML] Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1
BC Smith, RA Tinkey, OD Brock, A Mariam… - Journal of …, 2023 - Springer
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central
nervous system (CNS). Infiltrating inflammatory immune cells perpetuate demyelination and …
nervous system (CNS). Infiltrating inflammatory immune cells perpetuate demyelination and …
Metagenomics and chemotherapy‐induced nausea: A roadmap for future research
Uncontrolled chemotherapy‐induced nausea and vomiting can reduce patients' quality of
life and may result in premature discontinuation of chemotherapy. Although nausea and …
life and may result in premature discontinuation of chemotherapy. Although nausea and …
A type 2 diabetes subtype responsive to ACCORD intensive glycemia treatment
A Mariam, G Miller-Atkins, KM Pantalone… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Current type 2 diabetes (T2D) management contraindicates intensive glycemia
treatment in patients with high cardiovascular disease (CVD) risk and is partially motivated …
treatment in patients with high cardiovascular disease (CVD) risk and is partially motivated …
[HTML][HTML] Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer
Deleterious effects of environmental exposures may contribute to the rising incidence of
early-onset colorectal cancer (eoCRC). We assessed the metabolomic differences between …
early-onset colorectal cancer (eoCRC). We assessed the metabolomic differences between …
Diet quality indices and changes in cognition during chemotherapy
Purpose No evidence-based prevention strategies currently exist for cancer-related
cognitive decline (CRCD). Although patients are often advised to engage in healthy lifestyle …
cognitive decline (CRCD). Although patients are often advised to engage in healthy lifestyle …
Biomarkers for Response to Anti--PD-1/Anti--PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis.
BACKGROUND: Immune checkpoint inhibitors (ICIs) that block PD-1/PD-L1 have consistently
demonstrated durable clinical activity across multiple histologies but have low overall …
demonstrated durable clinical activity across multiple histologies but have low overall …
An interpretable predictive deep learning platform for pediatric metabolic diseases
Objectives Metabolic disease in children is increasing worldwide and predisposes a wide
array of chronic comorbid conditions with severe impacts on quality of life. Tools for early …
array of chronic comorbid conditions with severe impacts on quality of life. Tools for early …
[HTML][HTML] Identification of robust deep neural network models of longitudinal clinical measurements
Deep learning (DL) from electronic health records holds promise for disease prediction, but
systematic methods for learning from simulated longitudinal clinical measurements have yet …
systematic methods for learning from simulated longitudinal clinical measurements have yet …